AndreaBozzo/ceres-open-data-index huggingface dataset:
NNDSS - Table II. Rubella to Salmonellosis

NNDSS - Table II. Rubella to Salmonellosis - 2016.  In this Table, provisional* cases of selected† notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories.
Note:
These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. 

Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. 

Footnotes:
C.N.M.I.: Commonwealth of Northern Mariana Islands. 
U: Unavailable.    -: No reported cases.    N: Not reportable.    NN: Not Nationally Notifiable.   NP:  Nationally notifiable but not published.    Cum: Cumulative year-to-date counts.    Med: Median.    Max: Maximum. 

 * Case counts for reporting year 2016 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly.
† Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions.
Compound 525886: N,N-Dimethyl-N'-(4-ethoxyphenyl)-isobutyramidine

Chemical compound data from PubChem database. IUPAC Name: N'-(4-ethoxyphenyl)-N,N,2-trimethylpropanimidamide. Molecular Formula: C14H22N2O. Molecular Weight: 234.34. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526894: 2-(2-Isobutoxyethoxy)ethyl TMS ether

Chemical compound data from PubChem database. IUPAC Name: trimethyl-[2-[2-(2-methylpropoxy)ethoxy]ethoxy]silane. Molecular Formula: C11H26O3Si. Molecular Weight: 234.41. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529332: Oxetane, 3-methyl-3-phenoxymethyl

Chemical compound data from PubChem database. IUPAC Name: 3-methyl-3-(phenoxymethyl)oxetane. Molecular Formula: C11H14O2. Molecular Weight: 178.23. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
AFCARS Report #25

This report provides preliminary estimates of Adoption and Foster Care Analysis and Reporting System (AFCARS) data for FY 2017. As states are permitted to resubmit AFCARS data, the estimates may change over time. This report reflects all AFCARS data received as of August 10, 2018 related to AFCARS reporting periods through September 30, 2017.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 526094: Tetradecanoic acid, 12-methyl, trimethylsilyl ester

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 12-methyltetradecanoate. Molecular Formula: C18H38O2Si. Molecular Weight: 314.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529205: Butanoic acid, 2-amino, O,N,N-tris-TMS

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 2-[bis(trimethylsilyl)amino]butanoate. Molecular Formula: C13H33NO2Si3. Molecular Weight: 319.66. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525808: N,N'-bis-(3-Ethoxyphenyl)formamidine

Chemical compound data from PubChem database. IUPAC Name: N,N'-bis(3-ethoxyphenyl)methanimidamide. Molecular Formula: C17H20N2O2. Molecular Weight: 284.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528707: 2-Hydroxy-3,4,5-trimethyl-2-cyclopenten-1-one

Chemical compound data from PubChem database. IUPAC Name: 2-hydroxy-3,4,5-trimethylcyclopent-2-en-1-one. Molecular Formula: C8H12O2. Molecular Weight: 140.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528200: Benzoic acid, 2-hydroxy-3-(2,3-dihydroxy-2-methylpropyl), bis-DTBS

Chemical compound data from PubChem database. IUPAC Name: 2,2-ditert-butyl-8-[(2,2-ditert-butyl-4-methyl-1,3,2-dioxasilolan-4-yl)methyl]-1,3,2-benzodioxasilin-4-one. Molecular Formula: C27H46O5Si2. Molecular Weight: 506.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528288: Benzene, 1,2-dimethyl-3-propyl-

Chemical compound data from PubChem database. IUPAC Name: 1,2-dimethyl-3-propylbenzene. Molecular Formula: C11H16. Molecular Weight: 148.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Medicare Geographic Variation - by National, State & County

The Medicare Geographic Variation by National, State & County dataset provides information on the geographic differences in the use and quality of health care services for the Original Medicare population. This dataset contains demographic, spending, use, and quality indicators at the state level (including the District of Columbia, Puerto Rico, and the Virgin Islands) and the county level.

Spending is standardized to remove geographic differences in payment rates for individual services as a source of variation. In general, total standardized per capita costs are less than actual per capita costs because the extra payments Medicare made to hospitals were removed, such as payments for medical education (both direct and indirect) and payments to hospitals that serve a disproportionate share of low-income patients. Standardization does not adjust for differences in beneficiaries’ health status.
2020 National Directory of Mental Health Treatment Facilities

The National Directory of Mental Health Treatment Facilities - 2020 is a listing of federal, state, and local government facilities and private facilities that provide mental health treatment services. It includes treatment facilities that responded to the 2019 National Mental Health Services Survey (N-MHSS). The information about each facility that appears in this Directory was provided by that facility in response to the 2019 N-MHSS. The N-MHSS is conducted annually by the Substance Abuse and Mental Health Services Administration (SAMHSA).The Directory is ordered alphabetically by state, by city within each state, and by facility name within each city. Each facility listing includes codes that represent the services offered and other features of the facility, including codes that indicate services for hearing impaired and non-English-speaking clients. Codes are defined in a key shown on pages v-viii. Because the services offered by a particular facility may change over time, it is always a good idea to verify the information in this Directory when contacting a facility.
Compound 530027: Vanillyl alcohol, bis(trimethylsilyl)-

Chemical compound data from PubChem database. IUPAC Name: [2-methoxy-4-(trimethylsilyloxymethyl)phenoxy]-trimethylsilane. Molecular Formula: C14H26O3Si2. Molecular Weight: 298.52. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526738: Diethylene glycol, nonyl ether, TMS

Chemical compound data from PubChem database. IUPAC Name: trimethyl-[2-(2-nonoxyethoxy)ethoxy]silane. Molecular Formula: C16H36O3Si. Molecular Weight: 304.54. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Emergency Department Visits Attributed to Overmedication That Involved the Insomnia Medication Zolpidem

This short report uses data on drug-related emergency department (ED) visits to examine the involvement of zolpidem in ED visits that are related to overmedication.  Zolpidem is a medication used to treat insomnia.  Overmedication may occur when a patient takes too much of their own medications (i.e., exceeds the prescribed or recommended dose) but excludes drug-related suicide attempts.  The report looks at trends in zolpidem-related overmedication ED visits from 2005-2006 to 2009-2010 for both males and females.  It also looks at patterns by age group, the other types of drugs that are most commonly involved in the visits, and the outcome of the visits.
Compound 526857: 2-(2-(2-(2-Isobutoxy-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethyl acetate

Chemical compound data from PubChem database. IUPAC Name: 2-[2-[2-[2-[2-(2-methylpropoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethyl acetate. Molecular Formula: C16H32O7. Molecular Weight: 336.42. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530364: 1,2-Benzenediol, 4-methyl, bis-TMS

Chemical compound data from PubChem database. IUPAC Name: trimethyl-(4-methyl-2-trimethylsilyloxyphenoxy)silane. Molecular Formula: C13H24O2Si2. Molecular Weight: 268.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400021-T1: [Translated] METHOD FOR MAINTAINING COHERENCE BETWEEN MIRROR DATA STORES

The invention provides a storage device controller (200) adapted to be connected to a plurality of storage devices (300) provided with a plurality of storage volumes for storing data, said storage device controller being connectable to an information processing apparatus (100) for sending write requests to the storage volumes, wherein the storage device controller (200) comprises means for forming pairs of storage volumes, each pair bringing one of the plurality of storage volumes into correspondence with another storage volume. The storage device controller (200) is adapted to start to split pairs of a set of paired volumes upon receiving a split command for the set of paired volumes, wherein the storage device controller (200) is adapted to execute a write request being received during splitting the pairs of the set of paired volumes and being addressed to a volume in the set of paired volumes, after a completion of splitting a pair related to the volume in the set of paired volumes.
Quality Assurance Reporting Requirements (QARR) Health Disparities 2019

This dataset includes Medicaid Managed Care, Commercial HMO, and Commercial PPO performance data from the Quality Assurance Reporting Requirements (QARR) by member demographic characteristics. QARR is largely based on measures of quality developed and published by the National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS®). Plans are required to submit quality performance data each year. Demographic information analyzed in this report includes members’ sex, age, race/ethnicity, Medicaid aid category, cash assistance status, behavioral health conditions including serious mental illness (SMI) and substance use disorder (SUD), payer status, and region of residence. Measuring the quality of care, and the ability to measure disparities in care is an important first step to a better understanding of the underlying factors that drive differences in care among certain populations within Medicaid Managed Care, Commercial HMO, and Commercial PPO.

*Due to COVID-19 impacts, measures requiring hybrid review are not included in this dataset for year 2019.

These data are published annually for Medicaid Managed Care in the Health Care Disparities in New York State Report and on the NYSDOH website: http://www.health.ny.gov/health_care/managed_care/reports/
Child and Family Services Reviews Update Volume 13, Issue 3, July 2019

This issue of Child and Family Services Reviews Update contains the following sections: CFSR E-Training Platform Redesign and New Training Course, Recent Personnel Changes in CFSR Unit, Program Improvement Plans, Approvals Progressing for Round 3 CFSRs, PIP Pilots, Online Monitoring System Updates, Round 3 Aggregate Report, Years 2015-2017.

Metadata-only record linking to the original dataset. Open original dataset below.
2015 CMHS Uniform Reporting System (URS) Table for Arizona

2015 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Arizona. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
2008-2010 NSDUH Overview and Summary of Substate Region Estimation Methodology

This report discusses the methodology used in the 2008 to 2010 National Survey on Drug Use and Health (NSDUH) report that assesses past year alcohol use disorder and illicit drug use disorder among persons aged 12 or older by 362 substate regions within the 50 States and the District of Columbia. Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE).
A National Look at the Use of Congregate Care in Child Welfare

The U.S. Department of Health and Human Services, Administration for Children and Families, and the Children’s Bureau released a brief on the use of congregate care in the child welfare system. Through examining trends from the Adoption and Foster Care Analysis and Reporting System (AFCARS), federal, state, and local agencies were able to collect data elements which are designed to help policymakers and advocates better understand the population of children and youth who are likely to experience congregate care and what, if any, additional supports may be needed to further reduce reliance on it as a placement setting.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 529379: 3-Methyl-1,2,4-trithiolane

Chemical compound data from PubChem database. IUPAC Name: 3-methyl-1,2,4-trithiolane. Molecular Formula: C3H6S3. Molecular Weight: 138.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
National Estimates of Drug-Related Emergency Department Visits, 2004-2011 - Nonmedical Use of Pharmaceuticals

Excel file with national estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits involving the nonmedical use of pharmaceuticals (prescription and over-the-counter medications and dietary supplements), covering 2004-2011.  Nonmedical use includes patients who took a higher than prescribed or recommended dose of their own medication, patients who took a pharmaceutical prescribed for another person, malicious poisoning of the patient by another individual, and documented substance abuse involving pharmaceuticals.
Compound 526639: 2,3-Di-O-Acetyl-1,4-Anhydro-5-O-methyl-L-fucitol

Chemical compound data from PubChem database. IUPAC Name: [4-acetyloxy-5-(1-methoxyethyl)oxolan-3-yl] acetate. Molecular Formula: C11H18O6. Molecular Weight: 246.26. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
SHIP Infant Death Rate 2010-2021

Infant Death Rate - This indicator shows the infant mortality rate per 1,000 live births. Infant mortality has long been considered the most sensitive indicator of the overall health of a population. While there have been several decades of improvement in infant mortality, Maryland’s rate remains higher than the national average. <a href="https://health.maryland.gov/pophealth/Documents/SHIP/SHIP%20Lite%20Data%20Details/Infant%20Death%20Rate.pdf" > Link to Data Details </a>
Pathological apoptosis by xanthurenic acid, a tryptophan metabolite: activation of cell caspases but not cytoskeleton breakdown

Background
          A family of aspartate-specific cysteinyl proteases, named caspases, mediates programmed cell death, apoptosis. In this function, caspases are important for physiological processes such as development and maintenance of organ homeostasis. Caspases are, however, also engaged in aging and disease development. The factors inducing age-related caspase activation are not known. Xanthurenic acid, a product of tryptophan degradation, is present in blood and urine, and accumulates in organs with aging.
        
        
          Results
          Here, we report triggering of apoptotic key events by xanthurenic acid in vascular smooth muscle and retinal pigment epithelium cells. Upon exposure of these cells to xanthurenic acid a degradation of ICAD/DFF45, poly(ADP-ribose) polymerase, and gelsolin was observed, giving a pattern of protein cleavage characteristic for caspase-3 activity. Active caspase-3, -8 and caspase-9 were detected by Western blot analysis and immunofluorescence. In the presence of xanthurenic acid the amino-terminal fragment of gelsolin bound to the cytoskeleton, but did not lead to the usually observed cytoskeleton breakdown. Xanthurenic acid also caused mitochondrial migration, cytochrome C release, and destruction of mitochondria and nuclei.
        
        
          Conclusions
          These results indicate that xanthurenic acid is a previously not recognized endogenous cell death factor. Its accumulation in cells may lead to accelerated caspase activation related to aging and disease development.
Integrating Harm Reduction Strategies into Services and Supports for Young Adults Experiencing Homelessness

The Administration for Children and Families (ACF) is committed to promoting the economic and social well-being of children, youth, families, individuals, and communities. As part of our work, we support the HHS Overdose Prevention Strategy
  
  

 (OPS) to ensure individuals with a substance use disorder (SUD) are supported and connected to substance use treatment, human services, and other necessary resources. Harm reduction
  
  

, an evidence-based approach critical to engaging with people who use drugs and equipping them with life-saving tools and information, is one of the four priority areas in the agency’s overdose prevention strategy. This brief provides information and resources about harm reduction services for young adults experiencing homelessness.

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E399992-T1: [Translated] MATRIX POTENTIAL RESPONDERS

A matric potential responder which includes a liquid absorbing swellable nonliquid material (115) held within a housing (114) of a ceramic material environ such as soil, to the material (115), being subject to a compressive force such as a spring (116). This uses balance of compressive force as compared to tension of the soil matric potential being used to control a position of a valve (119) which is arranged to effect an output such as control of a mains water valve (110).
Compound 525913: N,N-Dimethyl-N'-phenyl-pivalamidine

Chemical compound data from PubChem database. IUPAC Name: N,N,2,2-tetramethyl-N'-phenylpropanimidamide. Molecular Formula: C13H20N2. Molecular Weight: 204.31. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2012 Uniform Reporting System (URS) Tables for Republic of Palau

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2012. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Carcinogenic Potency Database (CPDB)

Carcinogenic Potency Database (CPDB) is a single standardized resource of the results of 45 years of chronic, long-term carcinogenesis bioassays. The experiments vary widely in design, histopathological examination and nomenclature, and in the published authors’ choices of what information to publish in their papers.

Data are included from 6153 experiments reported in the general literature and in the in Technical Reports of the National Cancer Institute/National Toxicology Program (NCI/NTP). Information is given in the CPDB on strain, sex, route of compound administration, target organ, histopathology, author’s opinion about carcinogenicity, and reference to the published paper, as well as quantitative data on statistical significance, tumor incidence, dose-response curve shape, length of experiment, duration of dosing, and dose-rate.

The files on this Web site for the Excel format include (A) documentation of methods, field descriptions, and linking instructions; (B) Excel files; and (C) ancillary files of appendices. NOTE: This dataset is no-longer updated with new content.
Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain

The key enzyme in coronavirus polyprotein processing is the viral main proteinase, Mpro, a protein with extremely low sequence similarity to other viral and cellular proteinases. Here, the crystal structure of the 33.1 kDa transmissible gastroenteritis (corona)virus Mpro is reported. The structure was refined to 1.96 Å resolution and revealed three dimers in the asymmetric unit. The mutual arrangement of the protomers in each of the dimers suggests that Mpro self-processing occurs in trans. The active site, comprised of Cys144 and His41, is part of a chymotrypsin-like fold that is connected by a 16 residue loop to an extra domain featuring a novel α-helical fold. Molecular modelling and mutagenesis data implicate the loop in substrate binding and elucidate S1 and S2 subsites suitable to accommodate the side chains of the P1 glutamine and P2 leucine residues of Mpro substrates. Interactions involving the N-terminus and the α-helical domain stabilize the loop in the orientation required for trans-cleavage activity. The study illustrates that RNA viruses have evolved unprecedented variations of the classical chymotrypsin fold.